Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new coumadin clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on coumadin
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation
Status: Not yet recruiting, Condition Summary: Stroke; Atrial Fibrillation; Embolism - Genetic Determinants of Warfarin Anticoagulation Effect
Status: Recruiting, Condition Summary: Venous Thrombosis; Pulmonary Embolism; Atrial Fibrillation - Determinants of Warfarin Metabolism
Status: Recruiting, Condition Summary: Healthy - Relationship Between Folic Acid and Warfarin Metabolism and Effect
Status: Recruiting, Condition Summary: Folic Acid Deficiency - Drug Interaction Study of Rifampin and Warfarin in Healthy Volunteers.
Status: Not yet recruiting, Condition Summary: Healthy - Drug Interaction Study With a Potential Alzheimer's Disease Compound
Status: Active, not recruiting, Condition Summary: Alzheimer Disease - Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters
Status: Active, not recruiting, Condition Summary: Cancer-Related Problem/Condition - Odiparcil For The Prevention Of Venous Thromboembolism
Status: Completed, Condition Summary: Venous Thromboembolism; Deep Vein Thrombosis; Pulmonary Embolism - Evaluation of Weekly Subcutaneous Biotinylated Idraparinux Versus Oral Adjusted-Dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Status: Recruiting, Condition Summary: Atrial Fibrillation - A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers
Status: Completed, Condition Summary: Healthy Subjects - Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation
Status: Active, not recruiting, Condition Summary: Atrial Fibrillation; Atrial Flutter; Venous Thromboembolic Disease; Myocardial Infarction; Cardiomyopathy - Prophylaxis Against DVTs After Hip and Knee Surgery
Status: Not yet recruiting, Condition Summary: Thromboembolic Disease - Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism
Status: Recruiting, Condition Summary: Thromboembolism - Duloxetine - Warfarin Pharmacodynamic Study
Status: Completed, Condition Summary: Anticoagulant Effect of Warfarin When Taken With Duloxetine. - Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)
Status: Completed, Condition Summary: Venous Thromboembolism; Major Bleeding - Drug Interaction Study Between AZD3480 and Warfarin
Status: Recruiting, Condition Summary: Alzheimer's Disease - Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
Status: Recruiting, Condition Summary: Heart Disease; Stroke; Ischemic Heart Disease; Myocardial Infarction - Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information
Status: Recruiting, Condition Summary: Pulmonary Embolism; Deep Vein Thrombosis; Atrial Fibrillation - Effects of LMWH in Healthy Subjects Treated With TB-402 and Effects of TB-402 in Healthy Subjects Treated With Warfarin
Status: Completed, Condition Summary: Healthy - Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-Clavulanic Acid
Status: Active, not recruiting, Condition Summary: Oral Anticoagulation; Deep Venous Thrombosis; Atrial Fibrillation; Pulmonary Embolism - Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin
Status: Not yet recruiting, Condition Summary: Atrial Fibrillation - Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP)
Status: Recruiting, Condition Summary: Recurrent Venous Thromboembolism; Idiopathic Deep Vein Thrombosis - Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. "PADIS-PE" Study.
Status: Recruiting, Condition Summary: Pulmonary Embolism - A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"
Status: Completed, Condition Summary: Atrial Fibrillation; Deep Vein Thrombosis; Pulmonary Embolism - Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm
Status: Recruiting, Condition Summary: Atrial Fibrillation; Pulmonary Embolism; Deep Vein Thrombosis - Ongoing WARfarin and Coronary STENTing.
Status: Not yet recruiting, Condition Summary: Percutaneous Coronary Intervention - Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation
Status: Recruiting, Condition Summary: Bradycardia; Tachycardia; Atrial Fibrillation; Valvular Heart Disease - Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors
Status: Active, not recruiting, Condition Summary: Unspecified Adult Solid Tumor, Protocol Specific - Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients
Status: Recruiting, Condition Summary: Atrial Fibrillation; Heart Valve Diseases; Venous Thrombosis - A Study Testing Oral Dabigatran Etexilate vs Warfarin for 6 Month Treatment for Acute Symptomatic VTE
Status: Recruiting, Condition Summary: Thromboembolism